Kinetik Holdings Inc.

Kinetik reported Q4 adjusted EBITDA of $252M and full-year adjusted EBITDA of $988M, repurchased $176M of Class A stock and ended 2025 at 3.8x leverage after using about $500M of EPIC Crude sale proceeds to pay down the revolver. Management described 2025 as a difficult year and set a 2026 “rebuilding” mandate focused on execution, cost discipline and project delivery, guiding 2026 adjusted EBITDA of $950M–$1.05B, capex of $450M–$510M and a 3.5x–4.0x leverage target. The company completed strategic moves to boost capacity and reduce Waha exposure—Barilla Draw acquisition, Kings Landing full commercial service and FID on a sour-gas conversion—and amended contracts to shift residue pricing toward Gulf Coast and add fixed-fee structures to improve EBITDA visibility. Kinetik also took FID on a 40 MW behind-the-meter power project at Diamond Cryo and plans modest dividend increases and opportunistic buybacks under an updated capital allocation framework. » Altro su finance.yahoo.com

Kinetik Holdings reported Q4 2025 EPS of USD 2.16 (expectation USD 0.33) on revenue of USD 430.42m (expectation USD 476.77m). Adjusted EBITDA for Q4 was USD 252m, full-year EBITDA USD 988m; management cites strategic asset sales and debt reduction as drivers of the improved balance sheet. The stock rose 8.35% after-hours; the company forecasts 2026 adjusted EBITDA of USD 950m–1.05bn and CapEx of USD 450–510m. Strength was seen in the midstream logistics segment (+15%), while risks remain from the revenue decline, divestitures in pipeline transport and price volatility at the Waha hub. » Altro su de.investing.com

Die Aktie der Kinetik Holdings Inc. erreichte mit 39,33 USD ein neues 52-week-tief, obwohl InvestingPro die Aktie auf dem aktuellen Niveau als unterbewertet einstuft und eine attraktive Dividendenrendite von 7,8 % sowie dreijährige Dividendenerhöhungen meldet. Für Q2/2025 meldete Kinetik ein EPS von 0,33 USD (über den Erwartungen) bei einem Umsatz von 426,74 Mio. USD (unter den Schätzungen), und Goldman Sachs senkte das Kursziel von 49,00 USD auf 47,00 USD, beließ aber die Einstufung auf buy. Anleger beobachten weiterhin die Mischung aus operativen Herausforderungen, Dividendenstärke und Bewertungsargumenten für die weitere Kursentwicklung. » Altro su de.investing.com